We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Humana claims Mallinckrodt engaged in a “complex, multipart scheme involving monopoly, bribery, racketeering, fraud, and other deceptive and unfair practices.” Read More
Rep. Elijah Cummings (D-Md.) and Sen. Bernie Sanders (I-Vt.) are going after Teva, Mylan and Heritage Pharma again for allegedly obstructing a congressional inquiry into generic drug prices. Read More
The FDA is investigating the firm for failing to disclose problems with animal testing data until more than a month after the product was approved. Read More
Drugmakers were generally supportive but raised some questions and concerns in comments on the FDA’s draft guidance on increasing diversity in clinical trials. Read More
The FDA announced on Tuesday that it will begin removing out-of-date drug listing records from its database in one month and urged companies to update any inaccurate listings as soon as possible. Read More